A Pharmacogenetic Prediction Model of Progression‐Free Survival in Breast Cancer using Genome‐Wide Genotyping Data from CALGB 40502 (Alliance)

Genome‐wide genotyping data are increasingly available for pharmacogenetic association studies, but application of these data for development of prediction models is limited. Prediction methods, such as elastic net regularization, have recently been applied to genetic studies but only limitedly to pharmacogenetic outcomes. An elastic net was applied to a pharmacogenetic study of progression‐free survival (PFS) of 468 patients with advanced breast cancer in a clinical trial of paclitaxel, nab‐paclitaxel, and ixabepilone. A final model included 13 single nucleotide polymorphisms (SNPs) in addition to clinical covariates (prior taxane status, hormone receptor status, disease‐free interval, and presence of visceral metastases) with an area under the curve (AUC) integrated over time of 0.81, an increase compared to an AUC of 0.64 for a model with clinical covariates alone. This model may be of value in predicting PFS with microtubule targeting agents and may inform reverse translational studies to understand differential response to these drugs.

[1]  A. Hofman,et al.  Meta-analysis of genome-wide association studies on the intolerance of angiotensin-converting enzyme inhibitors , 2017, Pharmacogenetics and genomics.

[2]  Joseph T. Glessner,et al.  From Disease Association to Risk Assessment: An Optimistic View from Genome-Wide Association Studies on Type 1 Diabetes , 2009, PLoS genetics.

[3]  Trevor Hastie,et al.  Regularization Paths for Cox's Proportional Hazards Model via Coordinate Descent. , 2011, Journal of statistical software.

[4]  Francisco Azuaje,et al.  Computational models for predicting drug responses in cancer research , 2016, Briefings Bioinform..

[5]  Trevor J. Hastie,et al.  Genome-wide association analysis by lasso penalized logistic regression , 2009, Bioinform..

[6]  Valerie Obenchain,et al.  Risk prediction using genome‐wide association studies , 2010, Genetic epidemiology.

[7]  Bethany Percha,et al.  Genetic variant in folate homeostasis is associated with lower warfarin dose in African Americans. , 2014, Blood.

[8]  Elias Chaibub Neto,et al.  The Stream Algorithm: Computationally Efficient Ridge-Regression via Bayesian Model Averaging, and Applications to Pharmacogenomic Prediction of Cancer Cell Line Sensitivity , 2013, Pacific Symposium on Biocomputing.

[9]  Trevor Hastie,et al.  Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.

[10]  Cheng Cheng,et al.  Genomic architecture of pharmacological efficacy and adverse events. , 2014, Pharmacogenomics.

[11]  E. Stahl,et al.  Polygenic heritability estimates in pharmacogenetics: focus on asthma and related phenotypes , 2013, Pharmacogenetics and genomics.

[12]  Taesung Park,et al.  Joint Identification of Multiple Genetic Variants via Elastic‐Net Variable Selection in a Genome‐Wide Association Analysis , 2010, Annals of human genetics.

[13]  E. Boerwinkle,et al.  Pharmacogenomic Genome-Wide Meta-Analysis of Blood Pressure Response to &bgr;-Blockers in Hypertensive African Americans , 2016, Hypertension.

[14]  P. Waldmann,et al.  Evaluation of the lasso and the elastic net in genome-wide association studies , 2013, Front. Genet..

[15]  H. Zou,et al.  Regularization and variable selection via the elastic net , 2005 .

[16]  Yurii S. Aulchenko,et al.  BIOINFORMATICS APPLICATIONS NOTE doi:10.1093/bioinformatics/btm108 Genetics and population analysis GenABEL: an R library for genome-wide association analysis , 2022 .

[17]  E. Winer,et al.  Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance). , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  Joshua C Denny,et al.  Meta-analysis of genome-wide association studies of HDL cholesterol response to statins , 2016, Journal of Medical Genetics.

[19]  Yusuke Nakamura,et al.  Genome‐wide association study of chemotherapeutic agent‐induced severe neutropenia/leucopenia for patients in Biobank Japan , 2013, Cancer Science.

[20]  Artem Sokolov,et al.  Pathway-Based Genomics Prediction using Generalized Elastic Net , 2016, PLoS Comput. Biol..

[21]  Xiao Song,et al.  A semiparametric approach for the covariate specific ROC curve with survival outcome , 2008 .

[22]  Joseph O Deasy,et al.  Machine Learning on a Genome-wide Association Study to Predict Late Genitourinary Toxicity After Prostate Radiation Therapy. , 2018, International journal of radiation oncology, biology, physics.

[23]  Dermot F. Reilly,et al.  Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting , 2017, Circulation.

[24]  A. Di Rienzo,et al.  Genetic mapping with multiple levels of phenotypic information reveals determinants of lymphocyte glucocorticoid sensitivity. , 2013, American journal of human genetics.

[25]  Yusuke Nakamura,et al.  A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients , 2013, Breast Cancer Research.

[26]  V. Martinelli,et al.  Pharmacogenetic study of long-term response to interferon-β treatment in multiple sclerosis , 2015, The Pharmacogenomics Journal.

[27]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[28]  E. Gamazon,et al.  Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer , 2017, Clinical Cancer Research.

[29]  Anne-Christin Hauschild,et al.  GWAS-based machine learning approach to predict duloxetine response in major depressive disorder. , 2018, Journal of psychiatric research.

[30]  Zachary A. Szpiech,et al.  Whole‐Genome Sequencing of Pharmacogenetic Drug Response in Racially Diverse Children with Asthma , 2018, American journal of respiratory and critical care medicine.

[31]  Jun Wang,et al.  Predicting Anticancer Drug Responses Using a Dual-Layer Integrated Cell Line-Drug Network Model , 2015, PLoS Comput. Biol..

[32]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.